Speeding Up New Drug Launches, Avoiding Light, And Environmentally Friendly? See How These Small Labels Leverage This Market Innovation And Major Upgrade!

Speeding up new drug launches, avoiding light, and environmentally friendly? See how these small labels leverage this market innovation and major upgrade!

The core value of pharmaceutical labels is not to attract consumers' attention on cluttered shelves. Compared to other label categories that emphasize brand building and aesthetic design, the pharmaceutical label printing track places a strong emphasis on functionality, with extreme requirements for product performance, stability, and safety.

Pharmaceutical label application scenarios

Compared to ordinary label materials, pharmaceutical labels need to be adapted to various high-difficulty and demanding technical application scenarios. For example, pharmaceutical labels need to meet the requirements for fitting small-diameter syringes in low-temperature environments, while also possessing excellent chemical corrosion resistance.

In addition, pharmaceutical labels must be adapted to various sterilization processes, including high-pressure steam sterilization, ethylene oxide gas sterilization, gamma-ray irradiation, electron beam irradiation, and other sterilization processes.

Risk control of pharmaceutical labels

Compared to other industries, the pharmaceutical industry's product iteration and implementation process is extremely lengthy. The average cycle from R&D to market launch for a new drug is 10~15 years, with R&D investment reaching 1.3 billion~2.8 billion USD. It is worth noting that the review of new drug marketing applications not only focuses on the safety and efficacy of the drugs themselves, but also covers the entire drug packaging system. This requires pharmaceutical companies to have complete test data to confirm that all packaging components, including labeling materials, will not negatively affect drug quality or medication safety.

Therefore, the need for risk control on pharmaceutical labels is also very urgent. Drug efficacy and safety are the primary guidelines in the pharmaceutical industry. Pharmaceutical companies place great importance on controlling various risks arising from drug packaging system approvals and material changes, which sets higher standards for upstream label suppliers' quality control and service capabilities.

Any minor change in label materials could lead pharmaceutical companies to reconduct months-long drug stability tests, significantly increasing their time and R&D and production costs. In response to the unique qualification verification requirements of the pharmaceutical industry, it is recommended that label printing companies establish a comprehensive supporting service system, strictly control changes in product materials, proactively extend the notification cycle for product changes, and minimize customers' verification costs.

New trends in pharmaceutical labeling: photosensitive drug labels

Currently, upgrading photosensitive drug matching label technology is a key innovation direction for the industry. Light exposure can trigger photodegradation or other chemical reactions in large quantities of drugs, damaging drug stability and reducing efficacy-an issue that has become increasingly important in the industry. The biopharmaceutical market is huge. According to Grandview Research, the current market size is about $400 billion to $600 billion, and it is expected to surpass $1 trillion by 2030, further driving iteration in light-blocking label technology. Meanwhile, several new synthetic drugs such as oral glucagon-like peptide-1 (GLP-1) also have photosensitive properties, creating an urgent need for light-resistant labels.

To meet the rapid growth of the photosensitive drug market, some label material suppliers have accelerated R&D and launched a series of compatible label products, such as Avery Dennison's targeted introduction of a new series of UV-blocking label products. This series of UV-blocking materials can effectively avoid damage to pharmaceuticals caused by ultraviolet rays, stabilize their efficacy, and significantly extend the shelf storage life of photosensitive drugs. Among them, the transparent laminated film products combine UV protection with visual inspection functions, meeting the quality verification needs during the production of injectable drugs and providing strong support for pharmaceutical companies' quality control processes.

Sustainable progress in pharmaceutical labeling

Currently, the concept of sustainable development is gradually permeating the pharmaceutical labeling sector. While adhering to patient medication safety as the top priority, more and more pharmaceutical companies are actively integrating sustainable design concepts into new drug launches and existing drug packaging redesign projects, promoting green upgrades in pharmaceutical packaging.

Currently, the green transformation of pharmaceutical packaging is mainly focused on secondary packaging, where the industry generally replaces traditional plastic parts with paper trays and paper insert accessories. At the same time, disposable auto-injectors are gradually iterating toward multi-dose reuse models, effectively reducing the amount of medical waste landfilled and lowering the environmental burden on the industry.

In the R&D and implementation of sustainable pharmaceutical labeling materials, some labeling material suppliers are building diversified eco-friendly product matrices tailored to the differentiated green development goals of various pharmaceutical companies. Companies can provide various eco-labeling solutions based on customers' specific needs, including environmentally friendly virgin paper substrates, membrane backing paper containing recycled ingredients, and specialized adhesives suitable for recycling high-density polyethylene medicine bottles, to meet the green upgrade demands of mainstream oral solid dosage drug labels.